Cystic Fibrosis-Related Pancreatic Cysts Decrease in Size and Number Upon Treatment With Cystic Fibrosis Transmembrane Conductance Regulator Modulators

Pancreas. 2020 Jul;49(6):e50-e51. doi: 10.1097/MPA.0000000000001567.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Aminophenols / therapeutic use*
  • Aminopyridines / therapeutic use*
  • Benzodioxoles / therapeutic use*
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Drug Combinations
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Mutation
  • Pancreas / diagnostic imaging
  • Pancreas / drug effects*
  • Pancreas / pathology
  • Pancreatic Cyst / complications
  • Pancreatic Cyst / drug therapy*
  • Quinolones / therapeutic use*
  • Treatment Outcome
  • Ultrasonography / methods

Substances

  • Aminophenols
  • Aminopyridines
  • Benzodioxoles
  • CFTR protein, human
  • Drug Combinations
  • Indoles
  • Quinolones
  • lumacaftor, ivacaftor drug combination
  • tezacaftor, ivacaftor drug combination
  • Cystic Fibrosis Transmembrane Conductance Regulator